FOSPHENYTOIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fosphenytoin, and when can generic versions of Fosphenytoin launch?
Fosphenytoin is a drug marketed by Am Regent, Amneal, Apotex Inc, Dr Reddys, Fresenius Kabi Usa, Gland, Hikma, Hikma Farmaceutica, Hospira, Pharmobedient, Sun Pharm, and Wockhardt Bio Ag. and is included in fourteen NDAs.
The generic ingredient in FOSPHENYTOIN is fosphenytoin sodium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fosphenytoin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fosphenytoin
A generic version of FOSPHENYTOIN was approved as fosphenytoin sodium by FRESENIUS KABI USA on August 6th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FOSPHENYTOIN?
- What are the global sales for FOSPHENYTOIN?
- What is Average Wholesale Price for FOSPHENYTOIN?
Summary for FOSPHENYTOIN
| US Patents: | 0 |
| Applicants: | 12 |
| NDAs: | 14 |
| Drug Prices: | Drug price information for FOSPHENYTOIN |
| DailyMed Link: | FOSPHENYTOIN at DailyMed |


